The Valley Desk

NCT06961214 · Interventional trial

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Overall registry status Recruiting

Phase 3

Conditions Pulmonary Disease, Chronic Obstructive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov